What is the current annual D&A of ABBV?

As of today, ABBV annual D&A is $8.14B

What is 1-year change in ABBV annual D&A?

ABBV annual D&A is down -2.95% year-over-year

What is 3-year change in ABBV annual D&A?

ABBV annual D&A is down -3.87% over the past 3 years

How far is ABBV annual D&A from its all-time high?

ABBV annual D&A is currently -6.43% below its historical high of $8.70B set on December 31, 2023

How does ABBV annual D&A rank versus sector peers?

ABBV annual D&A is higher than 100.00% of companies in Healthcare sector

When is ABBV next annual earnings release?

The next annual earnings release for ABBV is on February 3, 2027

What is the current quarterly D&A of ABBV?

As of today, ABBV quarterly D&A is $1.86B

What is ABBV quarterly D&A most recent change?

ABBV quarterly D&A was down -1.17% on September 30, 2026

What is 1-year change in ABBV quarterly D&A?

ABBV quarterly D&A is down -9.79% year-over-year

How far is ABBV quarterly D&A from its all-time high?

ABBV quarterly D&A is currently -18.80% below its historical high of $2.29B set on September 30, 2020

How does ABBV quarterly D&A rank versus sector peers?

ABBV quarterly D&A is higher than 99.79% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

What is the current TTM D&A of ABBV?

As of today, ABBV TTM D&A is $7.67B

What is ABBV TTM D&A most recent change?

ABBV TTM D&A was down -2.57% on September 30, 2026

What is 1-year change in ABBV TTM D&A?

ABBV TTM D&A is down -7.11% year-over-year

How far is ABBV TTM D&A from its all-time high?

ABBV TTM D&A is currently -12.67% below its historical high of $8.78B set on September 30, 2023

How does ABBV TTM D&A rank versus sector peers?

ABBV TTM D&A is higher than 99.79% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

AbbVie Inc. (ABBV) Depreciation And Amortization History & Chart

Annual D&A

$8.14B$247.00M-2.95%

December 31, 2025

Summary

Current Value: As of today, ABBV annual D&A is $8.14B, down -2.95% on December 31, 2025
Historical Performance: ABBV annual D&A is down -3.87% over the past 3 years, up +25.78% over the past 5 years
All-Time High Comparison: ABBV annual D&A is currently -6.43% below its historical high of $8.70B set on December 31, 2023
3-Year Low Comparison: ABBV annual D&A is at its 3-year low
Sector Comparison: ABBV annual D&A is higher than 100.00% of companies in Healthcare sector

Depreciation & Amortization Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual D&A	Dec 31, 25	$8.14B	-3.0%	-3.9%	+25.8%	+587.2%
Quarterly D&A	Sep 30, 26	$1.86B	-9.8%	-16.7%	-12.5%	+490.4%
TTM D&A	Sep 30, 26	$7.67B	-7.1%	-12.7%	-10.9%	+709.3%
Price	Nov 13, 26	$295.03	+27.0%	+112.8%	+152.2%	–
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Annual Total Expenses	Dec 31, 25	$56.93B	+9.3%	+23.0%	+38.0%	+396.8%
Annual Operating Expenses	Dec 31, 25	$29.98B	+31.1%	+57.7%	+86.7%	+387.5%
Annual Revenue	Dec 31, 25	$61.16B	+8.6%	+5.3%	+33.5%	+291.1%

Depreciation & Amortization Highs

ABBV Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$8.70B	Dec 31, 23	-6.4%
5Y	$8.70B	Dec 31, 23	-6.4%
All	$8.70B	Dec 31, 23	-6.4%

Depreciation & Amortization Lows

ABBV Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$8.14B	Dec 31, 25	at low
5Y	$6.47B	N/A	+25.8%
All	$697.49M	Dec 31, 09	+1066.9%

Depreciation & Amortization History

Year	Value	Change
2025	$8.14B	-2.9%
2024	$8.39B	-3.6%
2023	$8.70B	+2.7%
2022	$8.47B	-0.6%
2021	$8.52B	+31.7%
2020	$6.47B	+220.8%
2019	$2.02B	+14.3%
2018	$1.77B	+17.6%
2017	$1.50B	+26.2%

Year	Value	Change
2016	$1.19B	+42.2%
2015	$836.00M	+6.4%
2014	$786.00M	-12.4%
2013	$897.00M	-22.0%
2012	$1.15B	-9.6%
2011	$1.27B	+7.4%
2010	$1.18B	+69.8%
2009	$697.49M	-

FAQ

What is the current annual D&A of ABBV?: As of today, ABBV annual D&A is $8.14B
What is 1-year change in ABBV annual D&A?: ABBV annual D&A is down -2.95% year-over-year
What is 3-year change in ABBV annual D&A?: ABBV annual D&A is down -3.87% over the past 3 years
How far is ABBV annual D&A from its all-time high?: ABBV annual D&A is currently -6.43% below its historical high of $8.70B set on December 31, 2023
How does ABBV annual D&A rank versus sector peers?: ABBV annual D&A is higher than 100.00% of companies in Healthcare sector
When is ABBV next annual earnings release?: The next annual earnings release for ABBV is on February 3, 2027

Quarterly D&A

$1.86B$22.00M-1.17%

September 30, 2026

Summary

Current Value: As of today, ABBV quarterly D&A is $1.86B, down -1.17% on September 30, 2026
Historical Performance: ABBV quarterly D&A is down -9.79% year-over-year, down -16.73% over the past 3 years
All-Time High Comparison: ABBV quarterly D&A is currently -18.80% below its historical high of $2.29B set on September 30, 2020
3-Year Low Comparison: ABBV quarterly D&A is at its 3-year low
Sector Comparison: ABBV quarterly D&A is higher than 99.79% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly D&A	Sep 30, 26	$1.86B	-1.2%	-9.8%	-16.7%	-12.5%
Annual D&A	Dec 31, 25	$8.14B	–	-3.0%	-3.9%	+25.8%
TTM D&A	Sep 30, 26	$7.67B	-2.6%	-7.1%	-12.7%	-10.9%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
Quarterly SG&A	Sep 30, 26	$4.09B	+12.5%	+14.5%	+21.2%	+32.6%
Quarterly Total Expenses	Sep 30, 26	$13.18B	-1.6%	-15.5%	+8.4%	+17.9%
Quarterly Operating Expenses	Sep 30, 26	$8.31B	+39.0%	+41.9%	+64.6%	+79.8%
Quarterly Revenue	Sep 30, 26	$17.40B	+2.4%	+10.3%	+25.0%	+21.4%

Quarterly D&A Highs

ABBV Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$2.06B	N/A	-9.8%
3Y	$2.24B	N/A	-16.7%
5Y	$2.26B	Jun 30, 23	-17.6%
All	$2.29B	Sep 30, 20	-18.8%

Quarterly D&A Lows

ABBV Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$1.86B	Sep 30, 26	at low
3Y	$1.86B	Sep 30, 26	at low
5Y	$1.86B	Sep 30, 26	at low
All	$158.00M	Mar 31, 15	+1077.8%

Quarterly D&A History

Month	Value	Change
Sep 2026	$1.86B	-1.2%
Jun 2026	$1.88B	-2.7%
Mar 2026	$1.94B	-2.6%
Dec 2025	$1.99B	-3.7%
Sep 2025	$2.06B	+0.6%
Jun 2025	$2.05B	+0.5%
Mar 2025	$2.04B	-3.0%
Dec 2024	$2.10B	+1.1%
Sep 2024	$2.08B	-2.4%
Jun 2024	$2.13B	+2.7%
Mar 2024	$2.07B	-0.1%
Dec 2023	$2.08B	-7.1%
Sep 2023	$2.24B	-1.1%
Jun 2023	$2.26B	+6.3%
Mar 2023	$2.13B	-1.4%
Dec 2022	$2.16B	-2.2%
Sep 2022	$2.21B	+7.5%
Jun 2022	$2.05B	-0.0%
Mar 2022	$2.05B	+3.7%
Dec 2021	$1.98B	-7.0%
Sep 2021	$2.13B	-3.3%
Jun 2021	$2.20B	-0.7%
Mar 2021	$2.22B	+7.3%
Dec 2020	$2.07B	-9.9%
Sep 2020	$2.29B	+47.4%
Jun 2020	$1.56B	+178.2%
Mar 2020	$559.00M	+9.8%
Dec 2019	$509.00M	+1.2%
Sep 2019	$503.00M	+0.2%
Jun 2019	$502.00M	-0.2%
Mar 2019	$503.00M	+13.8%
Dec 2018	$442.00M	+1.6%

Month	Value	Change
Sep 2018	$435.00M	-1.8%
Jun 2018	$443.00M	-0.4%
Mar 2018	$445.00M	+20.6%
Dec 2017	$369.00M	-2.6%
Sep 2017	$379.00M	0.0%
Jun 2017	$379.00M	+1.3%
Mar 2017	$374.00M	+14.0%
Dec 2016	$328.00M	+7.9%
Sep 2016	$304.00M	+5.2%
Jun 2016	$289.00M	+7.8%
Mar 2016	$268.00M	+2.7%
Dec 2015	$261.00M	+15.0%
Sep 2015	$227.00M	+19.5%
Jun 2015	$190.00M	+20.3%
Mar 2015	$158.00M	-18.1%
Dec 2014	$193.00M	+0.5%
Sep 2014	$192.00M	-5.0%
Jun 2014	$202.00M	+1.5%
Mar 2014	$199.00M	-0.5%
Dec 2013	$200.00M	-14.5%
Sep 2013	$234.00M	-0.8%
Jun 2013	$236.00M	+4.0%
Mar 2013	$227.00M	-26.5%
Dec 2012	$308.86M	+36.2%
Sep 2012	$226.81M	-23.1%
Jun 2012	$295.09M	-7.6%
Mar 2012	$319.24M	-1.7%
Dec 2011	$324.88M	+3.1%
Sep 2011	$315.23M	-0.7%
Jun 2011	$317.61M	+1.0%
Mar 2011	$314.48M	-

FAQ

What is the current quarterly D&A of ABBV?: As of today, ABBV quarterly D&A is $1.86B
What is ABBV quarterly D&A most recent change?: ABBV quarterly D&A was down -1.17% on September 30, 2026
What is 1-year change in ABBV quarterly D&A?: ABBV quarterly D&A is down -9.79% year-over-year
How far is ABBV quarterly D&A from its all-time high?: ABBV quarterly D&A is currently -18.80% below its historical high of $2.29B set on September 30, 2020
How does ABBV quarterly D&A rank versus sector peers?: ABBV quarterly D&A is higher than 99.79% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

TTM D&A

$7.67B$202.00M-2.57%

September 30, 2026

Summary

Current Value: As of today, ABBV TTM D&A is $7.67B, down -2.57% on September 30, 2026
Historical Performance: ABBV TTM D&A is down -7.11% year-over-year, down -12.67% over the past 3 years
All-Time High Comparison: ABBV TTM D&A is currently -12.67% below its historical high of $8.78B set on September 30, 2023
3-Year Low Comparison: ABBV TTM D&A is at its 3-year low
Sector Comparison: ABBV TTM D&A is higher than 99.79% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM D&A	Sep 30, 26	$7.67B	-2.6%	-7.1%	-12.7%	-10.9%
Annual D&A	Dec 31, 25	$8.14B	–	-3.0%	-3.9%	+25.8%
Quarterly D&A	Sep 30, 26	$1.86B	-1.2%	-9.8%	-16.7%	-12.5%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
TTM SG&A	Sep 30, 26	-$66.89B	-555.8%	-578.8%	-610.8%	-642.9%
TTM Revenue	Sep 30, 26	$66.01B	+2.5%	+10.7%	+19.7%	+19.7%

TTM D&A Highs

ABBV TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$8.25B	N/A	-7.1%
3Y	$8.78B	N/A	-12.7%
5Y	$8.78B	Sep 30, 23	-12.7%
All	$8.78B	Sep 30, 23	-12.7%

TTM D&A Lows

ABBV TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$7.67B	Sep 30, 26	at low
3Y	$7.67B	Sep 30, 26	at low
5Y	$7.67B	Sep 30, 26	at low
All	$314.48M	Mar 31, 11	+2338.0%

TTM D&A History

Month	Value	Change
Sep 2026	$7.67B	-2.6%
Jun 2026	$7.87B	-2.1%
Mar 2026	$8.04B	-1.3%
Dec 2025	$8.14B	-1.4%
Sep 2025	$8.25B	-0.2%
Jun 2025	$8.27B	-1.0%
Mar 2025	$8.35B	-0.4%
Dec 2024	$8.39B	+0.3%
Sep 2024	$8.36B	-1.8%
Jun 2024	$8.52B	-1.5%
Mar 2024	$8.65B	-0.6%
Dec 2023	$8.70B	-0.9%
Sep 2023	$8.78B	+0.3%
Jun 2023	$8.75B	+2.4%
Mar 2023	$8.54B	+0.9%
Dec 2022	$8.47B	+2.1%
Sep 2022	$8.29B	+0.9%
Jun 2022	$8.21B	-1.8%
Mar 2022	$8.36B	-1.9%
Dec 2021	$8.52B	-1.0%
Sep 2021	$8.61B	-1.9%
Jun 2021	$8.77B	+7.9%
Mar 2021	$8.13B	+25.6%
Dec 2020	$6.47B	+31.7%
Sep 2020	$4.92B	+57.2%
Jun 2020	$3.13B	+50.8%
Mar 2020	$2.07B	+2.8%
Dec 2019	$2.02B	+3.4%
Sep 2019	$1.95B	+3.6%
Jun 2019	$1.88B	+3.2%
Mar 2019	$1.82B	+3.3%
Dec 2018	$1.77B	+4.3%

Month	Value	Change
Sep 2018	$1.69B	+3.4%
Jun 2018	$1.64B	+4.1%
Mar 2018	$1.57B	+4.7%
Dec 2017	$1.50B	+2.8%
Sep 2017	$1.46B	+5.4%
Jun 2017	$1.39B	+6.9%
Mar 2017	$1.30B	+8.9%
Dec 2016	$1.19B	+6.0%
Sep 2016	$1.12B	+7.4%
Jun 2016	$1.05B	+10.5%
Mar 2016	$946.00M	+13.2%
Dec 2015	$836.00M	+8.9%
Sep 2015	$768.00M	+4.8%
Jun 2015	$733.00M	-1.6%
Mar 2015	$745.00M	-5.2%
Dec 2014	$786.00M	-0.9%
Sep 2014	$793.00M	-5.0%
Jun 2014	$835.00M	-3.9%
Mar 2014	$869.00M	-3.1%
Dec 2013	$897.00M	-10.8%
Sep 2013	$1.01B	+0.7%
Jun 2013	$998.67M	-5.6%
Mar 2013	$1.06B	-8.0%
Dec 2012	$1.15B	-1.4%
Sep 2012	$1.17B	-7.0%
Jun 2012	$1.25B	-1.8%
Mar 2012	$1.28B	+0.4%
Dec 2011	$1.27B	+34.3%
Sep 2011	$947.32M	+49.9%
Jun 2011	$632.09M	+101.0%
Mar 2011	$314.48M	-

FAQ

What is the current TTM D&A of ABBV?: As of today, ABBV TTM D&A is $7.67B
What is ABBV TTM D&A most recent change?: ABBV TTM D&A was down -2.57% on September 30, 2026
What is 1-year change in ABBV TTM D&A?: ABBV TTM D&A is down -7.11% year-over-year
How far is ABBV TTM D&A from its all-time high?: ABBV TTM D&A is currently -12.67% below its historical high of $8.78B set on September 30, 2023
How does ABBV TTM D&A rank versus sector peers?: ABBV TTM D&A is higher than 99.79% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv